Skip to main content
OpenTrials
Completed

NCT Number: NCT07643389

EXCEL-Punjabi: A Culturally Tailored Exercise Oncology Pilot Feasibility Intervention

The goal of this pilot feasibility study is to explore the feasibility and exploratory effects of a culturally-tailored exercise oncology intervention in Punjabi-speaking individuals of South Asian heritage and their support persons. The main questions it aims to answer are:

1. What is the feasibility and acceptability of the EXCEL-Punjabi intervention? 2. What are the exploratory effects (i.e., psychosocial and physical changes) before and after program delivery?

Participants will take part in a 12-week exercise oncology intervention consisting of twice weekly hour long multimodal circuit-based exercise sessions. They will also complete questionnaires and functional fitness assessments pre- and post- intervention.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Cancer Behavior Motor Activity Neoplasms

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Genesis Centre Calgary

Calgary, Alberta, T2N 1N4, Canada

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Punjabi-speaking
  • Self-identified as being of South Asian heritage
  • over the age of 18
  • pre-, post-, or currently receiving cancer treatment or a support person of an individual living with and beyond cancer
  • cleared to participate in, at minimum, mild intensity exercise by a Clinical Exercise Physiologist
  • Able to provide informed consent

Exclusion criteria

  • under the age of 18
  • not cleared to exercise by a Clinical Exercise Physiologist

Treatment and study plan

EXCEL-Punjabi

Behavioral

Culturally Tailored Exercise Oncology Intervention

Primary outcomes

  1. Measurement Completion

    Time frame: Baseline to the end of the intervention (12 weeks)

    Participants who completed all pre- and post- questionnaires and functional assessments

Secondary outcomes

  1. Referrals

    Time frame: Baseline to end of intervention (12 weeks)

    Number of participants referred to intervention

  2. Consented

    Time frame: Recruitment to end of intervention (12 weeks)

    Number of participants who consented to participate in the intervention

  3. Enrolled

    Time frame: Baseline (week 0)

    Number of participants who enrolled (i.e. completed baseline assessments)

  4. Attendance

    Time frame: Baseline to end of intervention (12 weeks)

    Intervention Attendance

  5. Adverse Events

    Time frame: Baseline to end of intervention (12 weeks)

    Using the standardized Common Terminology Criteria for Adverse Events Version 6.0

  6. Time Required to Deliver and Implement Intervention

    Time frame: From recruitment to end of intervention (12 weeks)

    Time requirement to deliver intervention

  7. Physical Activity Level

    Time frame: Baseline to end of intervention (12 weeks)

    The Godin Leisure Time Exercise Questionnaire is used to determine subjective levels of physical activity in each participant. Participants report how many times per week they partake in mild, moderate, and/or strenuous exercise. Higher scores indicate a more physically active lifestyle.

  8. Cancer related symptoms

    Time frame: Baseline to end of intervention (12 weeks)

    Change in Edmonton Symptom Assessment Scale - revised: cancer. Scale is from 0-10, where 0 means the symptom is absent and 10 means the worst possible severity of the symptom is being experienced.

  9. Health Related Quality of Life

    Time frame: Baseline to end of intervention (12 weeks)

    Change in EuroQual - 5Dimensions (EQ-5D) tool - first section is a questionnaire; last section uses a scale from 0-100, where 0 means the worst health imaginable and 100 means the best health imaginable.

  10. Fatigue

    Time frame: Baseline to end of intervention (12 weeks)

    Change in Functional Assessment of Chronic Illness Therapy - Fatigue subscale - scale is from 0-4, where 0 means "not at all" and 4 means "very much".

  11. Cancer Related Quality of Life

    Time frame: Baseline to end of intervention (12 weeks)

    A 5-point Likert scale (0 = not at all, to 4 = very much) to track wellbeing over the course of the cancer journey.

  12. Exercise Barriers Self-Efficacy

    Time frame: Baseline to end of intervention (12 weeks)

    Exercise barriers and facilitators questionnaire

  13. Cognition

    Time frame: Baseline to end of intervention (12 weeks)

    Cancer related cognition using the Functional Assessment of Cancer Therapy - Cognition questionnaire. A 37-item, self-report questionnaire used to evaluate how cancer patients perceive their own cognitive abilities

  14. Aerobic Capacity

    Time frame: Baseline to end of intervention (12 weeks)

    In-person participants will be assessed on change in 6-minute walk test (m) results

  15. Aerobic Capacity

    Time frame: Baseline to end of intervention (12 weeks)

    Online participants will be assessed with change in the 2-minute step test (number of steps) results.

  16. Lower body strength

    Time frame: Baseline to end of intervention (12 weeks)

    Change in sit-to-stand (number of repetitions in 30 seconds)

  17. Upper extremity flexibility

    Time frame: Baseline to end of intervention (12 weeks)

    Change in active shoulder flexion range of motion (degrees)

  18. Balance

    Time frame: Baseline to end of intervention (12 weeks)

    Change in one legged stance test (seconds)

Sponsors and collaborators

Lead sponsor

University of Calgary

Other

Collaborators

  • Canadian Institutes of Health Research (CIHR)

Registry information

Official study title

EXCEL-Punjabi: Tailored Exercise Oncology for the South Asian Population

Acronym: EXCEL-Punjabi

Important dates

Study start
2025
Primary completion
2025
Study completion
2025
First posted
Jun 11, 2026
Registry last updated
Jun 11, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.